Coherus Oncology (CHRS) Goodwill & Intangibles: 2014-2025
Historic Goodwill & Intangibles for Coherus Oncology (CHRS) over the last 11 years, with Sep 2025 value amounting to $49.5 million.
- Coherus Oncology's Goodwill & Intangibles fell 8.89% to $49.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.5 million, marking a year-over-year decrease of 8.89%. This contributed to the annual value of $53.6 million for FY2024, which is 25.15% down from last year.
- According to the latest figures from Q3 2025, Coherus Oncology's Goodwill & Intangibles is $49.5 million, which was down 5.41% from $52.3 million recorded in Q2 2025.
- Over the past 5 years, Coherus Oncology's Goodwill & Intangibles peaked at $71.7 million during Q4 2023, and registered a low of $3.6 million during Q1 2021.
- Over the past 3 years, Coherus Oncology's median Goodwill & Intangibles value was $53.0 million (recorded in 2025), while the average stood at $45.9 million.
- Per our database at Business Quant, Coherus Oncology's Goodwill & Intangibles soared by 1,108.45% in 2023 and then fell by 25.15% in 2024.
- Coherus Oncology's Goodwill & Intangibles (Quarterly) stood at $3.6 million in 2021, then surged by 66.46% to $5.9 million in 2022, then soared by 1,108.45% to $71.7 million in 2023, then fell by 25.15% to $53.6 million in 2024, then decreased by 8.89% to $49.5 million in 2025.
- Its Goodwill & Intangibles stands at $49.5 million for Q3 2025, versus $52.3 million for Q2 2025 and $53.0 million for Q1 2025.